Summary of "FRCPath Part 2 Q&A: By Dr Ahmed Ali"

Main ideas, concepts, and lessons conveyed

Overall purpose of the session

• Dr Ahmed Ali explains how the FRCPath Part 2 exam works, focusing on:
  • Written OSP (OSP 1) / Written OSP section
  • Management OSP (OSP 2) / Management station
• He repeatedly emphasizes the importance of structure/approach, not “clever guessing.”

---

Methodology / Exam preparation framework (detailed bullets)

A) Written OSP (OSP 1) — “what they test” and “how to answer”

Question structure (typical pattern)

• Early questions (diagnosis + clinicopathologic context)
  • You’ll be shown clear, textbook-type morphology (e.g., malignant melanoma, adenocarcinoma, dysplastic lesions, etc.).
  • Tasks can include:
    • State the diagnosis
    • Provide main prognostic factors
• Later questions (molecular aspects)
  • The college aims to test molecular knowledge, but using common/real-life scenarios.

Common molecular scenarios / cancer areas he expects

• Breast: ERBB2/HER2 testing (example used), and related significance/implications.
• Melanoma: BRAF (including v600) testing and treatment implications.
• Multiple cancers: common panels such as:
  • Lung: PD-L1, ALK, EGFR (mentioned)
  • Colorectal: mismatch repair genes (MLH1, MSH2, MSH6, PMS2 implied) and the value of testing (e.g., implications for patients and families, recurrence/synchronous tumors).

Key testing methods you should know and compare

• IHC (immunohistochemistry)
  • Advantages he claims you can reasonably state:
    • widely available in labs
    • relatively interpretable by pathologists
    • good for “common” scenarios
  • Disadvantages he expects you to mention:
    • false positives/false negatives
    • depends on technical/antibody performance
    • requires periodic verification; cross-reactivity with other conditions
• FISH
  • Expected: explain pros/cons relative to IHC and “why it may fail” (he emphasizes general failure reasons like cellularity/technical factors).
• Real-time PCR / PCR
  • Expected: pros/cons (he stresses knowing “for/against” conceptually).
• Rapid gene sequencing
  • Expected: pros/cons (conceptual comparison; he indicates it’s one of the commonly used options in England).

Answer format strategy for scoring

• Use point format in the written OSP because:
  • it’s easier for examiners to score
  • it forces concise, systematic coverage
• For molecular testing questions:
  • present advantages in ~3 points
  • present disadvantages in ~2–3 points
  • no long essays required

Guidance about morphology pictures

• He warns against overcomplicating:
  • If the picture is “textbook,” the diagnosis should be straightforward.
• The primary “fatal” failure mode is:
  • not recognizing the obvious diagnosis from the provided image.

Why time exhaustion matters

• The only major risk he highlights is losing focus when exhausted.
• His solution: memorize an “all-trades” template you can apply to any case:
  • microscopy → diagnosis/prognostic factors → molecular with pros/cons across the methods

---

B) Management OSP (OSP 2) — “what they test” and “how to structure”

Typical format

• You enter a room with examiners.
• You receive a scenario card (short; described as ~5–6 lines).
• You must talk for roughly 10–12 minutes, with time for examiner questions.

Immediate best practice (within the station)

• Bring an empty piece of paper and quickly write:
  • your main points from the scenario
  • the conflict (who is involved)
  • obstacles affecting patient safety

Core structure he recommends

• Identify 3 main issues in the scenario:
  • Issue 1 / Issue 2 / Issue 3 (each with what needs to happen)
• Identify the people/persons involved
  • He uses a, b, c style labeling.
• Explain conflict + sensitivity + patient safety

What examiners look for

• Buzzwords / professional standards
  • Terminology aligned with UK practice and regulation, including:
    • incident reporting
    • learning from mistakes
    • reflection
    • protecting (patient safety, avoid harming)
    • maintaining professional relationships, confidentiality, and good medical practice
  • He references the GMC “Good medical practice” framework as a source of nine domains/expectations (to incorporate some of them).
• Understanding how labs work
  • Before-receipt, receipt/processing, reporting steps:
    • where sample mismatch or mix-ups could occur
    • possible causes at each stage (acquisition, processing, reporting)
• Hierarchical UK system
  • He outlines a hierarchy (clinical team up through leadership such as board/chief executive).

How to handle difficult examiner questions

• If asked about actions like “strike colleague from work”:
  • You must not decide personally.
  • Emphasize:
    • decisions belong to higher authorities
    • require thorough investigation and detailed analysis
    • follow the hierarchical system

Incident reporting categories to mention

• Major incident / patient harm
• Near miss
• Minor incident

Timing discipline

• He recommends:
  • do not over-talk
  • pause, summarize, and explicitly stop if needed
• Examiner question time is part of the scoring:
  • if they ask questions, it’s an opportunity—don’t assume lack of questions was their fault.

Repeated emphasis

• Be systematic and organized.
• Don’t “bluff” or dump uncontrolled information.

---

Resources / what to focus on for study

Written OSP (OSP 1)

• Main resource type
  • UK pathology “datasets” (described as the exam’s “bible” in practice).
  • Guidelines from major societies (iconic/guideline papers suggested).
• How much reading
  • Preparation can be done using:
    • guideline/summary papers (sometimes ~2–3 pages)
    • about 12–15 pages total to cover the whole part (his estimate)
• What to prioritize
  • “Big” commonly tested cancers and their markers:
    • melanoma (and related molecular markers like BRAF)
    • breast (HER2/ERBB2)
    • colorectal (mismatch repair)
    • lung markers
    • kidney/miscellaneous noted broadly
  • He explicitly downplays the need for exhaustive rare-entity learning.

Management OSP (OSP 2)

• He says there aren’t the same direct “sources” as for molecular topics.
• Instead, prepare by learning:
  • errors in pathology
  • how incident reporting works
  • GMC approach
  • UK hierarchy and MDT/communication norms
  • patient safety-first reasoning

---

Additional exam tips mentioned (non-exhaustive, but major themes)

Long case / macro / cytology / frozen section (high-level guidance)

• Long cases
  • Renal + lymphoid appear frequently; liver may appear with patterns described as part of how the exam rotates.
  • “CPC correlation” must be included, or you lose marks.
• Frozen section
  • Framed as “black/white/uncertain” triage:
    • clearly benign
    • benign vs malignant uncertain (“cannot decide” / defer appropriately)
    • clearly malignant
  • Key is safe handling, including lab precautions (especially with infectious/granulomatous scenarios).
• Cytology
  • Emphasis on:
    • seeing many cytology cases (suggested scale: ~3000)
    • relying on available classifications/guidelines (Paris/Milan mentioned)
• General exam behavior
  • Don’t revise aggressively in the last 1–2 days—he warns it can cause mental blocks and “half-knowledge” errors.
  • On exam day:
    • calibrate eyes on slides (especially cytology)
    • practice speed/structure for IHC reporting tables.

---

Speakers / sources featured

• Speaker: Dr Ahmed Ali (consultant pathologist in the United Kingdom; works in Essex; also describes training candidates/contracting sessions).
• Institutions / frameworks referenced:
  • GMC (General Medical Council) “Good medical practice”
  • Royal College of Pathologists (datasets, errors/incidents resources)
  • Society guidelines / “ICONIC papers” (general reference to society-published molecular guidance)
• Classifications / guideline systems mentioned:
  • Paris classification (cytology)
  • Milan classification (cytology)
• Specific guideline/dataset examples mentioned in passing:
  • Pathology “datasets” for cancers such as breast, colorectal, melanoma, kidney, adrenal, etc. (referred to repeatedly as the main exam basis; not named as a single document title in the transcript).

Category

Educational

---

Share this summary

Share on X/Twitter Share on Facebook Share on LinkedIn Share on Reddit Share on WhatsApp Share on Telegram

---

Is the summary off?

If you think the summary is inaccurate, you can reprocess it with the latest model.

Reprocess summary

Video